AKE logo
AKE
Arkema

New Capacity And R&D Focus Will Accelerate Renewable Transition

AN
AnalystConsensusTarget
AnalystConsensusTarget
Not Invested
Consensus Narrative from 16 Analysts
Published
05 Dec 24
Updated
07 Aug 25
AnalystConsensusTarget's Fair Value
€77.50
19.5% undervalued intrinsic discount
07 Aug
€62.35
Loading
1Y
-21.1%
7D
7.5%

Author's Valuation

€77.5

19.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates8

Shared on01 May 25
Fair value Decreased 20%

Read more

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on17 Apr 25
Fair value Decreased 2.36%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on09 Apr 25
Fair value Increased 24%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on02 Apr 25
Fair value Decreased 22%

Read more

Shared on26 Mar 25
Fair value Decreased 0.43%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on19 Mar 25
Fair value Increased 22%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on12 Mar 25
Fair value Decreased 5.54%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more